梅州怀孕什么时候适合流产梅州治疗子宫内膜炎的症状,梅州白带多是为什么,梅州盆腔腹膜炎有哪些症状,梅州人流好的妇科医院,梅州检查妇科需要多少钱,梅州得了霉菌性阴道炎怎么治疗,梅州隆鼻修复手术价格是多少

SAN DIEGO, Calif. – What’s usually a marathon for biotech companies is now a full-blown sprint to stop the spread of coronavirus.Kate Broderick, the Senior Vice President of R&D at Inovio Pharmaceuticals in San Diego, remembers the moment she first learned about the mysterious outbreak unfolding thousands of miles away. “Yes, absolutely, distinctly, probably one of those moments you’ll remember forever. I was in my kitchen at home the 31st of December,” said Broderick.She never imagined that two months later it would be the crisis it is today. “Every week I keep thinking it’s going to get better, it’s going to start to tone down a little bit, but in fact, rather than getting better it’s getting worse every week,” said Broderick.Inovio has made headlines before, creating vaccines for Zika, Ebola, and now the coronavirus. After Chinese researchers shared the genetic sequence of COVID-19, Inovio designed a vaccine in just three hours Using its proprietary DNA medicines platform technology. The vaccine was designed to precisely match the DNA sequence of the virus“In an outbreak setting we really don’t have two to three years to wait for a vaccine, so that’s where we come in at Inovio pharmaceuticals, we use DNA medicine technology,” said Broderick.While traditional vaccines use the virus itself, this method puts DNA inside E.coli, which naturally replicates the medicine over and over. The paste is then purified, leaving behind only the DNA medicine, which Inovio hopes to test in humans next month.“Infectious diseases are global and they don’t care about boundaries and borders, everyone is affected from childhood all the way through seniors,” said Phyllis Arthur, who’s been in the infectious disease industry for 20 years.Arthur is Vice President of Infectious Diseases and Diagnostic Policy at BIO, an association made up of about 1,000 companies.“One of the things we’re seeing, from outbreak to outbreak, unfortunately, is we’re getting faster at using platform technologies to build something that can be tried in humans sooner than we were the last time,” said Arthur.She’s following dozens of companies working on vaccines, treatments, and diagnostic tools. If their vaccines work, companies like Inovio will have to figure out how to manufacture them fast.“You may have the best vaccine in the world, but if you can only produce 1,000 doses of it, that’s not really going to help 1.4 billion people in China,” said Broderick. Continued funding will also be critical. Broderick says while their Zika vaccine looked promising in humans, it never ultimately got FDA approval for broad public use.“The problem there was, although great for global health, was that of course cases of the virus really steadily declined, the problem for us there was so did the funding,” said Broderick.She says that way of thinking is shortsighted but does see change on the horizon. “It’s a huge amount of responsibility on everyone’s shoulders, and I think we feel genuinely compelled to do everything in our power, hence why no one complains about two hours of sleep, because this is a point in our careers we can truly, literally, make a difference in saving lives, right now,” said Broderick.After the company begins human trials in the U.S., they’ll continue testing in China and South Korea. They hope to deliver one million doses by the end of the year.If they make it that far, it too would be a day Broderick will never forget. 3462

shout out to alex velez for reppin' gran varones today at the philadelphia pride kick-off event. thanks @PhillyLGBTgov for inviting gv! ???? pic.twitter.com/bSk4TJ9y5k— quarantinx (@GranVarones) June 9, 2017 220

Strong opioid dosage is the topic of a two-day public hearing by the Food and Drug Administration — which is trying to discern the benefits and risks.For Katrina King, her opioid addiction began with a back injury. It got so bad she spent two years behind bars after getting caught with forged prescriptions. King blames being put on high-dose medication too strong for her injury."The extended release — introducing that into the picture as such a potent dose so early in my diagnosis without trying anything else — ended up being catastrophic," she said.Some people have suggested the FDA remove high-dose opioids form the market to fight the deadly epidemic. Others argue the stronger meds are necessary to manage pain for some patients and getting rid of it could worsen pain for those people, leading to potential suicides."We don't want to cause additional suffering for people who have unmanageable pain that does make them feel they don't want to live anymore. On the other side of that, I would challenge the pharmaceutical industry and the FDA to come up with other methods of pain control," King said.The FDA will review public comments and decide whether to make change, which could include tougher regulations on reducing the use of high-dose opioids. 1276

Surveillance video of police officers firing at shooter can be viewed above. Due to the graphic nature of the content, some may find the video disturbing.DAYTON, Ohio — Of all the politicians and everyday people who praised 236

Sprouts Farmers Market is recalling its Frozen Cut Leaf Spinach due to listeria concerns. The recall affects both the regular and organic 16-ounce bags.According to the 181